Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas

Retraction in: /etm/7/6/1803

  • Authors:
    • Yuan Yue
    • Yumin Yang
    • Lei Shi
    • Zuoren Wang
  • View Affiliations

  • Published online on: October 10, 2013     https://doi.org/10.3892/etm.2013.1340
  • Pages: 1380-1384
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to investigate the expression and significance of a disintegrin and metalloproteinase 10 (ADAM10), epidermal growth factor receptor (EGFR) and E‑cadherin protein in hepatocellular carcinomas. The expression levels of ADAM10, EGFR and E‑cadherin were analyzed in 40 cases of hepatocellular carcinoma using immunohistochemistry and quantitative polymerase chain reaction (qPCR). The expression levels of ADAM10, EGFR and E-cadherin were significantly correlated with portal vein thrombosis, intrahepatic metastasis, differentiation degree and tumor size (P<0.05). In hepatocellular carcinoma, the expression levels of ADAM10 and EGFR were increased and the levels of E‑cadherin were decreased compared with those in the adjacent tissues. The elevated expression levels of ADAM10 and EGFR may be associated with the malignancy of the tumors. E‑cadherin expression is negatively correlated with the degree of malignancy. The detection of ADAM10, EGFR and E‑cadherin expression levels may contribute to an understanding of the oncogenesis and development of hepatocellular carcinomas.

Retracted

Related Articles

Journal Cover

December 2013
Volume 6 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yue Y, Yang Y, Shi L and Wang Z: Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas Retraction in /etm/7/6/1803. Exp Ther Med 6: 1380-1384, 2013
APA
Yue, Y., Yang, Y., Shi, L., & Wang, Z. (2013). Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas Retraction in /etm/7/6/1803. Experimental and Therapeutic Medicine, 6, 1380-1384. https://doi.org/10.3892/etm.2013.1340
MLA
Yue, Y., Yang, Y., Shi, L., Wang, Z."Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas Retraction in /etm/7/6/1803". Experimental and Therapeutic Medicine 6.6 (2013): 1380-1384.
Chicago
Yue, Y., Yang, Y., Shi, L., Wang, Z."Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas Retraction in /etm/7/6/1803". Experimental and Therapeutic Medicine 6, no. 6 (2013): 1380-1384. https://doi.org/10.3892/etm.2013.1340